Pacific Biosciences of California (PACB): Net earnings per share (EPS TTM)
Pacific Biosciences revenues are based on the sale of Revio and Onso systems along with consumables. The rolling annual earnings per share reflect the sales dynamics of HiFi high-precision equipment for biopharmaceutical corporations. Within the long-read B2B ecosystem, a stable payment stream from laboratories is being established, while the value of -0.43 serves as the current indicator of the company's fundamental profit.
Metric breakdowns and analytics for PacBio Corp (PACB)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt and liquidity data:
Total Debt to Capital Pacific Biosciences|PACB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Pacific Biosciences of California, Inc.|PACB - Company Cumulative Debt|Debt to Book Capitalization Ratio PacBio|PACB - Long-Term Debt Volume|Company Short-Term Debts PacBio|Quick Ratio pacb.com
- earnings and valuation multiples indicators:
PACB - Net Financial Result|Projected Future Earnings Pacific Biosciences|PACB - Market Cap to Earnings|Future Price to Earnings Pacific Biosciences|PACB - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple PacBio Corp|PACB - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) PacBio|PACB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months pacb.com|PACB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Pacific Biosciences
- issuer revenue and sales details:
Basic company analysis:PACB - Pacific Biosciences of California, Inc.
For Pacific Biosciences (PACB), which advances R&D through strategic alliances rather than costly acquisitions, this metric serves as a key measure of organic growth efficiency and the capitalization of internal innovations. By analyzing the 12-month net income per share snapshot on GURU.Markets, an investor can discern the business's actual unit profitability, stripped of the impact of share issuance, allowing for an objective assessment of the asset's fundamental value without market premiums.
Competitors of Pacific Biosciences
TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|RARE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics Inc)|Earnings per share for the trailing year SRPT|twistbioscience.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TXG (10x Genomics, Inc.)|NTLA: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months STOK (Stoke Therapeutics, Inc.)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|BNTC: Earnings per share for the trailing year|Earnings per share for the last twelve months Design Corp (DSGN)|Net earnings per share for the last 12 months Rocket Pharmaceuticals Inc RCKT|FDMT: Net earnings per one share for the last twelve months|LXEO: Earnings per share for the last 12 months|Korro Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Editas Medicine|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)
